MarketsandMarkets projects the global urinalysis market will grow from USD 4.88 billion in 2026 to USD 7.16 billion by 2031 at an 8.0% CAGR. Consumables held 72.5% of the urinalysis market in 2025, pregnancy and fertility tests accounted for 42.8%, and North America was the largest region, while Asia Pacific is expected to grow fastest. Demand is supported by urinary tract infections, diabetes, kidney and liver diseases, aging populations, routine screening, point-of-care testing, healthcare investment and automation. In a separate but related broader-market forecast issued on the same date, MarketsandMarkets projected the global point-of-care diagnostics market would rise from USD 20.63 billion in 2026 to USD 31.46 billion by 2031 at an 8.8% CAGR, with glucose monitoring the largest product segment, hospitals and urgent care the largest end-user segment, and home care, self-testing and Asia Pacific key growth opportunities.